News
The Alpha-1 Project names Jean-Marc Quach, longtime leader in healthcare management and marketing, as executive director
MIAMI — Jean-Marc D. Quach, a longtime leader in healthcare management and marketing, has been named executive director of The Alpha-1 Project, a subsidiary of the Alpha-1 Foundation.
Quach, of Englewood Cliffs, NJ, is not a newcomer to the world of Alpha-1 Antitrypsin Deficiency. From 1999-2004, he was vice president and general manager of Express Scripts Specialty Distribution Services, where he worked with AlphaNet and Bayer to create a “direct distribution” model for Prolastin®, then the only Alpha-1 augmentation treatment available. The business model is still used for orphan and other high-risk or shortage-prone drug products.
“Jean-Marc, with his record of leadership and innovation, is the perfect match for the Foundation’s initiative to speed the development of new therapies for Alpha-1,” said John W. Walsh, Foundation president and CEO.
